Marseille-Kliniken AG

euro adhoc: Marseille-Kliniken AG
Financing, Stock Offerings (IPO)
- Another substantial sale-and-leaseback business is concluded - CIT Group purchases 10 portfolio properties in the care and rehabilitation sector for over EUR117m - Significant imp

-------------------------------------------------------------------------------- Disclosure announcement transmitted by euro adhoc. The issuer is responsible for the content of this announcement. -------------------------------------------------------------------------------- 06.12.2005 Berlin, 6th December 2005. Marseille-Kliniken AG (Prime Standard, ISIN DE 0007783003, MKA) was able to successfully conclude after the GE deal a second substantial sale-and-leaseback contract with the properties investor CIT Group Europe, Great Britain. This involves Marseille-Kliniken AG selling a total of 10 portfolio properties, 8 of which are from the care sector and two from the rehabilitation sector, with approximately 1,550 beds to the English investor by means of a sale-and-leaseback agreement, and at the same time renting them back in the long term. With a volume of over EUR117m, this transaction sets another new milestone in the Marseille-Kliniken AG’s strategy of concentrating primarily on the health facilities business in future, and expanding their overall bed capacity to 12,000 beds by the year 2008. Once successfully implemented, the Marseille-Kliniken AG’s property portfolio will be distributed between approx. 30% facilities of their own and 70% rented facilities, and will therefore represent a ratio which the company had set themselves as their target. With this transaction, Marseille-Kliniken AG are able to pay off long-term financial debts, it considerably improves their capital ratio, and it creates further financial scope for the implementation of their growth strategy. end of announcement euro adhoc 06.12.2005 10:25:38 -------------------------------------------------------------------------------- ots Originaltext: Marseille-Kliniken AG Im Internet recherchierbar: Further inquiry note: Marseille-Kliniken AG Axel Hölzer CEO Alte Jakobstraße 79/80 10709 Berlin Tel.: 030 / 246 32-400 Fax: 030 / 246 32-401 Hillermann Consulting Christian Hillermann Investor Relations Eppendorfer Baum 5 20249 Hamburg Tel.: 040 / 414 069-13 Fax: 040 / 414 069-14 Branche: Pharmaceuticals ISIN: DE0007783003 WKN: 778300 Index: CDAX, Classic All Share, Prime All Share Börsen: Frankfurter Wertpapierbörse / official dealing/prime standard Berliner Wertpapierbörse / free trade Baden-Württembergische Wertpapierbörse / free trade Börse Düsseldorf / free trade Bremer Wertpapierbörse (BWB) / free trade Hamburger Wertpapierbörse / official dealing

Das könnte Sie auch interessieren: